ISSN : 1301-5680
e-ISSN : 2149-8156
Turkish Journal of Thoracic and Cardiovascular Surgery     

GENERAL CONSIDERATIONS

Online editorial office: All manuscripts and editorial correspondence must be submitted online to the editorial office at http://tgkdc.dergisi.org. Detailed submission information is provided at the online editorial office website. Each submission is assigned a unique number and acknowledged by e-mail.

Language: The official language of the journal is English.

Exclusive publication statement: Each author must certify that none of the material in the manuscript has been published previously in either print or electronic form and that none of the submitted material is currently under consideration for publication elsewhere. This includes symposia, transactions, books, invited articles, posting in electronic format and preliminary publications of any kind except an abstract of 400 words or fewer.

Authors are responsible for all (ethical, scientific, legal, etc.) content of their published material.

Review: The peer-review process is double-blind, i.e., both authors and referees are kept anonymous. The pre-evaluation process of each submission is carried out by the Editorial Board. Manuscripts may be rejected without peer review by the editor-in-chief if they do not comply with the instructions to authors or if they are beyond the scope of the journal. Any manuscript that does not conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as reported at http://www.icmje.org/icmje-recommendations.pdf, will also be rejected. Manuscripts are scanned for plagiarism or duplication. In case of an ethical issue on plagiarism or duplication, the Editorial Board will act in accordance with the Committee on Publication Ethics (COPE). The manuscripts are assigned to at least two double-blind peer-reviewers. Reviewers are selected among independent experts with publications in the international literature on the submission subject and a considerable amount of citations. Research articles, systematic reviews, and meta-analyses may also be reviewed by a biostatistician at the discretion of the editor. By submitting a manuscript to the journal, authors accept that editors may implement changes on their manuscripts including misleading statements and mistyping, as long as the main points of the manuscript are not altered. The Editor-in-Chief is the final authority in the decision-making process for all submissions.

Revisions: When submitting a revised version of a paper, the author must submit a detailed "Response to the reviewers" that states point by point how each issue raised by the reviewers has been covered and where it can be found (each reviewer’s comment, followed by the author’s reply and line numbers where the changes have been made) as well as an annotated copy of the main document. Revised manuscripts must be submitted within 30 days from the date of the decision letter. If the revised version of the manuscript is not submitted within the allocated time, the revision option may be canceled. If the submitting author(s) believe that additional time is required, they should request this extension before the initial 30-day period is over. Accepted manuscripts are copy-edited for grammar, punctuation, and format. Once the publication process of a manuscript is completed, it is published online on the journal’s webpage as an ahead-of-print publication before it is included in its scheduled issue. A PDF proof of the accepted manuscript is sent to the corresponding author and their publication approval is requested within two days of their receipt of the proof. The latest status of the submitted manuscripts and other information about the journal can be accessed at http://tgkdc.dergisi.org/.

Acceptance: The submitted papers will be published upon the editorial board's approval. 

Copyright transfer: Authors submitting to the Turkish Journal of Thoracic and Cardiovascular Surgery approve a copyright transfer to the Turkish Society of Cardiovascular Surgery. This transfer is finalized with the acceptance of the manuscript. The published manuscript cannot be used elsewhere, in whole or in part.

Conflict of interest statement: Any financial grants or other support received for the study from individuals or institutions must be disclosed to the Editorial Board and the International Committee of Medical Journal Editors (ICMJE) Potential Conflict of Interest Disclosure Form must be filled and submitted to disclose potential conflicts of interest. The manuscripts must be prepared in accordance with ICMJE Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (updated in December 2014 - http://www.icmje.org/icmje-recommendations.pdf). 

Clinical Trials and Reporting Guidelines: Authors are required to prepare manuscripts in accordance with the CONSORT guidelines for randomized research studies, the STROBE guidelines for the observational original research studies, the STARD guidelines for the diagnostic accuracy studies, the PRISMA guidelines for systematic reviews and metaanalyses, the ARRIVE guidelines for the experimental animal studies, and the TREND guidelines for non-randomized public behaviors.

For further information on the reporting guidelines for health research, authors are suggested to refer to the EQUATOR network website (http://www.equator-network.org/)

Ethical considerations: An approval of research protocols by the Ethics Committee in accordance with international agreements (Helsinki Declaration, revised 2013, Guide for the Care and Use of Laboratory Animals - https://www.nap.edu/catalog/5140.html/) is required for experimental, clinical, and investigational drug studies, and some case reports. The ethics committee reports or a corresponding official document is requested from the authors. In manuscripts reporting the results of an experimental study, it must be stated within the main text that all patients were informed in detail on the treatments and that informed consent was obtained from each patient. For studies carried out on animals, the measures taken to prevent pain and suffering of the animals must be explicitly stated. Information on the patient consent, the name of the ethics committee, and the ethics committee approval number must also be stated in the Patients and Methods section of the manuscript. It is the author’s responsibility to carefully protect the patients’ anonymity. For photographs that may reveal the identity of the patient, signed releases of the patient or his/her legal representative must be enclosed.

Plagiarism: Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with similarity and without citation. If evidence of plagiarism is found before/after acceptance or after the publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s). The journal checks all submissions for plagiarism and verifies the originality of content before publication.